IGC Pharma

IGCNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$24.587 M

$0.26 +2.68%

Close of 7 Aug 2026

Revenue

$1.27M

#3484 by revenue

Earnings

-$7.12M

Loss-making

Shares outstanding

98,796,089

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#383Aytu BiopharmaAYTU$25.3M
#384Actinium PharmaceuticalsATNM$25.0M
#385IGC PharmaIGC$24.6M
#386Barinthus BiotherapeuticsBRNS$24.5M
#387LongeveronLGVN$24.2M

Where these numbers come from

Share counts and financials for IGC Pharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.